Qingdao Haier Biomedical Co.,Ltd (SHA:688139)
China · Delayed Price · Currency is CNY 30.82
-0.18 (-0.58%)
At close: Sep 11, 2026
SHA:688139 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 997.82 | 843.83 | 901.23 | 1,269 | 951.78 | 774.39 |
Trading Asset Securities | 553.59 | 447.59 | 877.25 | 651.14 | 2,024 | 2,130 |
Cash & Short-Term Investments | 1,551 | 1,291 | 1,778 | 1,920 | 2,975 | 2,904 |
Cash Growth | 7.26% | -27.39% | -7.39% | -35.46% | 2.45% | 28.69% |
Accounts Receivable | 493.26 | 445.28 | 352.76 | 208.35 | 192.17 | 136.29 |
Other Receivables | 7.92 | 8.05 | 8.56 | 7.47 | 3.99 | 32 |
Receivables | 501.18 | 453.33 | 361.32 | 215.82 | 196.16 | 168.29 |
Inventory | 333.94 | 345.47 | 334.74 | 248.02 | 270.55 | 345.75 |
Prepaid Expenses | - | - | 0.14 | 2.56 | 1.21 | 0.41 |
Other Current Assets | 419.18 | 568.62 | 177.77 | 149.21 | 45.19 | 38.23 |
Total Current Assets | 2,806 | 2,659 | 2,652 | 2,536 | 3,489 | 3,457 |
Property, Plant & Equipment | 938.94 | 923.01 | 915.18 | 862.22 | 802.08 | 464.13 |
Long-Term Investments | 867.64 | 981.39 | 972.71 | 1,030 | 371.85 | 358.34 |
Goodwill | 757.72 | 758.24 | 757.87 | 642.68 | 451.3 | 323.45 |
Other Intangible Assets | 338.6 | 360.5 | 402.3 | 367.73 | 312.35 | 241.62 |
Long-Term Deferred Tax Assets | 100.07 | 89.67 | 66.01 | 51.67 | 30.52 | 35.43 |
Long-Term Deferred Charges | 5.48 | 5.6 | 6.72 | 5.69 | 5.46 | 0.5 |
Other Long-Term Assets | 12.55 | 14.25 | 14.24 | 29.18 | 26.91 | 19.53 |
Total Assets | 5,827 | 5,792 | 5,787 | 5,526 | 5,489 | 4,900 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 485.55 | 429.38 | 427.6 | 390.98 | 485.06 | 431.57 |
Accrued Expenses | 228.55 | 242.19 | 228.65 | 235.15 | 245.6 | 196.05 |
Short-Term Debt | 10.01 | 10.01 | 10.01 | 6.01 | 10.01 | - |
Current Portion of Long-Term Debt | 9.99 | 10 | - | - | - | - |
Current Portion of Leases | 4 | 5.01 | 5.76 | 3.42 | 5.48 | 1.65 |
Current Income Taxes Payable | 19.26 | 23.66 | 35.21 | 35.8 | 28.68 | 48.01 |
Current Unearned Revenue | 105 | 170.92 | 151.98 | 111.81 | 232.84 | 362.05 |
Other Current Liabilities | 192.4 | 194.33 | 163.2 | 158.51 | 176.81 | 104.17 |
Total Current Liabilities | 1,055 | 1,085 | 1,022 | 941.66 | 1,184 | 1,144 |
Long-Term Leases | 2.94 | 4.54 | 7.43 | 8.69 | 10.67 | 4.32 |
Long-Term Unearned Revenue | 50.34 | 26.08 | 23.17 | 28.62 | 32.88 | 32.18 |
Long-Term Deferred Tax Liabilities | 42.76 | 45.89 | 52.51 | 46.99 | 43.59 | 25.9 |
Other Long-Term Liabilities | 6.54 | 6.31 | 63.81 | 59.75 | 69.03 | 55.18 |
Total Liabilities | 1,157 | 1,168 | 1,169 | 1,086 | 1,341 | 1,261 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 316.49 | 317.95 | 317.95 | 317.95 | 317.95 | 317.07 |
Additional Paid-In Capital | 1,885 | 1,976 | 1,977 | 1,987 | 1,995 | 1,913 |
Retained Earnings | 2,367 | 2,323 | 2,219 | 2,015 | 1,751 | 1,309 |
Treasury Stock | -149.71 | -248.68 | -140.2 | -99.74 | -98.07 | - |
Comprehensive Income & Other | 2.99 | 7.46 | -2.69 | 10.37 | 53.89 | 84.34 |
Total Common Equity | 4,421 | 4,376 | 4,372 | 4,231 | 4,021 | 3,623 |
Minority Interest | 247.96 | 247.5 | 246.59 | 209.25 | 127.71 | 15.95 |
Shareholders' Equity | 4,669 | 4,623 | 4,618 | 4,440 | 4,148 | 3,639 |
Total Liabilities & Equity | 5,827 | 5,792 | 5,787 | 5,526 | 5,489 | 4,900 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 26.93 | 29.55 | 23.2 | 18.11 | 26.15 | 5.97 |
Net Cash (Debt) | 1,524 | 1,262 | 1,755 | 1,902 | 2,949 | 2,898 |
Net Cash Growth | 7.69% | -28.11% | -7.73% | -35.50% | 1.76% | 29.86% |
Net Cash Per Share | 4.89 | 4.03 | 5.55 | 6.00 | 9.28 | 9.12 |
Filing Date Shares Outstanding | 312.84 | 311.71 | 314.48 | 315.68 | 316.49 | 317.07 |
Total Common Shares Outstanding | 312.84 | 311.75 | 314.48 | 316.47 | 316.49 | 317.07 |
Working Capital | 1,751 | 1,573 | 1,630 | 1,594 | 2,304 | 2,313 |
Book Value Per Share | 14.13 | 14.04 | 13.90 | 13.37 | 12.70 | 11.43 |
Tangible Book Value | 3,325 | 3,257 | 3,211 | 3,220 | 3,257 | 3,058 |
Tangible Book Value Per Share | 10.63 | 10.45 | 10.21 | 10.18 | 10.29 | 9.64 |
Buildings | 792.73 | 785.74 | 696.63 | 649.88 | 257.73 | 243.72 |
Machinery | 385.45 | 359.68 | 333.52 | 284.75 | 240.79 | 151.04 |
Construction In Progress | 76.11 | 54.97 | 95.03 | 70.33 | 389.34 | 130.96 |